Acute Pancreatitis with Liraglutide – Acknowledgements
An analysis of MedWatch adverse event reports submitted to the Food and Drug Administration in the first two years following approval
June 5, 2014
- Cover Letter to the FDA (pdf)
- Full Report (pdf)
- View the Press Release
- June 17, 2014 – FDA Response
- Executive Summary
- Part 1: Background
- Part 2: Methods
- Part 3: Results
- Part 4: Discussion
- Part 5: Conclusion
- Acknowledgements
- Appendix: Charts & Graphs
ACKNOWLEDGEMENTS
We are grateful to Greta Gorman, the Health Research Group’s previous managing editor, for her meticulous editing of the manuscript draft, to Quantesa Roberts and Alex Zaslow, former Health Research Group staffers, for their help compiling the data and formatting the tables, respectively, and to Sarah Sorscher, Health Research Group staff attorney, for helpful suggestions on the final draft.
Next Page » Appendix: Charts & Graphs